Menu Back to Global-AE-Reporting-Drug-Safety-Requirements-in-the-US-and-EU

Program Committee

  • JP  Clement, MD
    JP Clement, MD Consultant
    JP Clement Pharmacovigilance Consulting, United States
  • Steve  Jolley, MA
    Steve Jolley, MA Chief Executive Officer
    SJ Pharma Consulting, LLC, United States
  • Andre  Daniels, MD, MS
    Andre Daniels, MD, MS Executive Director, Global Regulatory Affairs and Safety
    Amgen, Inc., United States
  • Sylvie  Tomczyk, MD, PhD
    Sylvie Tomczyk, MD, PhD Senior Medical Director
    EMD Serono, United States
Load More